HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of fresh blood to control severe haemorrhage associated with massive blood transfusion after cardiopulmonary bypass.

Abstract
A 61-year-old man with severe factor XI deficiency presented for coronary artery bypass surgery. The clotting deficiency was corrected preoperatively with factor XI concentrate. Surgery resulted in severe postoperative haemorrhage of 55 liters of blood. This was managed successfully with a cell saver device (Haemonetics). Repeated platelet transfusions were ineffective in correcting the platelet dysfunction. The severe haemorrhage stopped suddenly after the infusion of 4 units of fresh blood. The case demonstrates how fresh blood can be useful in the management of severe haemorrhage after massive blood transfusion.
AuthorsA Macfie, J Goiti, J Hunsley
JournalEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (Eur J Cardiothorac Surg) Vol. 4 Issue 3 Pg. 171-3 ( 1990) ISSN: 1010-7940 [Print] Germany
PMID2334557 (Publication Type: Case Reports, Journal Article)
Topics
  • Blood Transfusion
  • Cardiopulmonary Bypass (adverse effects)
  • Factor XI Deficiency (complications)
  • Hemorrhage (etiology, therapy)
  • Humans
  • Internal Mammary-Coronary Artery Anastomosis (adverse effects)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: